Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eddy Anglade currently holds 56,000 shares of Ocata Therapeutics, Inc. (OCAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eddy Anglade has been a net neutral trader of OCAT stock. They have purchased $0 and sold $0 worth of shares.
Eddy Anglade's most recent insider trade was on Feb 10, 2016, when they sold 56,000 shares at $8.50 per share.
Eddy Anglade serves as Executive at Ocata Therapeutics, Inc. (OCAT). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Eddy Anglade holds the position of Executive at Ocata Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Eddy Anglade has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Eddy Anglade was on Feb 10, 2016, when they sold $476.0K worth of OCAT shares. This transaction involved 56,000 shares at $8.50 per share.
Eddy Anglade currently owns 56,000 shares of Ocata Therapeutics, Inc. (OCAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eddy Anglade's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eddy Anglade has 2 Form 4 filings on record as an insider at Ocata Therapeutics, Inc..
Set alerts for Eddy Anglade and 40,000+ other insiders.